DOCSLIB.ORG

Table II. List of Genes Differentially Expressed Between High and Low Risk Endometrial Carcinomas

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Table II. List of Genes Differentially Expressed Between High and Low Risk Endometrial Carcinomas Table II. List of genes differentially expressed between high and low risk endometrial carcinomas Fold Change ID Symbol Entrez Gene Name Type of molecule (high vs low risk) ACSL6 ACSL6 acyl-CoA synthetase long-chain family member 6 -1,053 enzyme ACTRT2 ACTRT2 actin-related protein T2 -1,207 other ALKBH3 ALKBH3 alkB, alkylation repair homolog 3 (E. coli) 1,016 enzyme ARMC3 ARMC3 armadillo repeat containing 3 -1,250 other ARPC5 ARPC5 actin related protein 2/3 complex, subunit 5, 16kDa 1,045 other ATG4C ATG4C ATG4 autophagy related 4 homolog C (S. cerevisiae) -1,233 peptidase C14orf70 C14ORF70 chromosome 14 open reading frame 70 1,025 other C17orf78 C17ORF78 chromosome 17 open reading frame 78 -1,418 other C1orf88 C1ORF88 chromosome 1 open reading frame 88 -1,055 other C5orf34 C5ORF34 chromosome 5 open reading frame 34 -1,085 other CASC2 CASC2 cancer susceptibility candidate 2 1,021 other transcription CIAO1 CIAO1 cytosolic iron-sulfur protein assembly 1 homolog (S. cerevisiae) -1,430 regulator COG5 COG5 component of oligomeric golgi complex 5 -1,176 transporter COL17A1 COL17A1 collagen, type XVII, alpha 1 -1,196 other COX4I1 COX4I1 cytochrome c oxidase subunit IV isoform 1 -1,123 enzyme CPSF3 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa -1,380 other CRYBB1 CRYBB1 crystallin, beta B1 -1,214 other DAPK3 DAPK3 death-associated protein kinase 3 -1,063 kinase G-protein coupled DARC DARC Duffy blood group, chemokine receptor 1,024 receptor DIDO1 DIDO1 death inducer-obliterator 1 1,027 other DNAH17 DNAH17 dynein, axonemal, heavy chain 17 -1,188 other DSCAM DSCAM Down syndrome cell adhesion molecule -1,097 other ECHDC2 ECHDC2 enoyl CoA hydratase domain containing 2 -1,190 other translation EIF4A1 EIF4A1 eukaryotic translation initiation factor 4A1 -1,155 regulator family with sequence similarity 19 (chemokine (C-C motif)-like), FAM19A5 FAM19A5 member A5 -1,450 other FBXL22 FBXL22 F-box and leucine-rich repeat protein 22 1,022 other transcription FOXQ1 FOXQ1 forkhead box Q1 -1,329 regulator GCNT3 GCNT3 glucosaminyl (N-acetyl) transferase 3, mucin type 1,024 enzyme GP9 GP9 glycoprotein IX (platelet) -1,211 other G-protein coupled GPR63 GPR63 G protein-coupled receptor 63 -1,133 receptor G-protein coupled GPRC5D GPRC5D G protein-coupled receptor, family C, group 5, member D -1,113 receptor HAP1 HAP1 huntingtin-associated protein 1 1,023 other HMGB3 HMGB3 high-mobility group box 3 -1,096 other HPN HPN hepsin -1,432 peptidase HSFX1 HSFX1 heat shock transcription factor family, X linked 1 -1,087 other HYI HYI hydroxypyruvate isomerase homolog (E. coli) 1,035 enzyme KIAA1632 KIAA1632 KIAA1632 -1,125 other KIAA1919 KIAA1919 KIAA1919 1,033 other KRT6B KRT6B keratin 6B -1,132 other Q8WX68_HUMAN LOC286297 hypothetical protein LOC286297 -1,231 other Q96K35_HUMAN LOC84931 hypothetical LOC84931 1,022 other LYN LYN v-yes-1 Yamaguchi sarcoma viral related oncogene homolog -1,030 kinase MFSD3 MFSD3 major facilitator superfamily domain containing 3 -1,429 other p-value <0.001 Table II. List of genes differentially expressed between high and low risk endometrial carcinomas (continuation) Fold Change ID Symbol Entrez Gene Name Type of molecule (high vs low risk) MPP2 MPP2 membrane protein, palmitoylated 2 -1,101 kinase MRFAP1L1 MRFAP1L1 Morf4 family associated protein 1-like 1 -1,223 other APPBP1 NAE1 NEDD8 activating enzyme E1 subunit 1 1,024 enzyme NBPF14 NBPF14 neuroblastoma breakpoint family, member 14 -1,196 other NIPBL NIPBL Nipped-B homolog (Drosophila) -1,321 other transcription NKX6-2 NKX6-2 NK6 homeobox 2 -1,085 regulator transcription NPAS1 NPAS1 neuronal PAS domain protein 1 -1,228 regulator NXT2 NXT2 nuclear transport factor 2-like export factor 2 -1,114 transporter OR7A2_HUMAN OR7A2P olfactory receptor, family 7, subfamily A, member 2 pseudogene -1,168 other phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 PDE4B PDE4B dunce homolog, Drosophila) 1,031 enzyme transcription PHF12 PHF12 PHD finger protein 12 1,025 regulator PLA2G5 PLA2G5 phospholipase A2, group V -1,146 enzyme pleckstrin homology domain containing, family G (with RhoGef PLEKHG5 PLEKHG5 domain) member 5 -1,353 other Q9UHS2_HUMAN PPP1R8 protein phosphatase 1, regulatory (inhibitor) subunit 8 -1,055 phosphatase Q9P175_HUMAN PRO2268 hypothetical protein PRO2268 -1,123 other PUS7L PUS7L pseudouridylate synthase 7 homolog (S. cerevisiae)-like -1,156 other RAB11FIP1 RAB11FIP1 RAB11 family interacting protein 1 (class I) -1,180 other RAB11FIP3 RAB11FIP3 RAB11 family interacting protein 3 (class II) 1,024 other RAP1GDS1 RAP1GDS1 RAP1, GTP-GDP dissociation stimulator 1 -1,099 other RDH10 RDH10 retinol dehydrogenase 10 (all-trans) -1,206 enzyme transcription REST REST RE1-silencing transcription factor 1,025 regulator RFC4 RFC4 replication factor C (activator 1) 4, 37kDa -1,173 other RGL1 RGL1 ral guanine nucleotide dissociation stimulator-like 1 -1,439 other RPS24 RPS24 ribosomal protein S24 1,020 other SLC4A11 SLC4A11 solute carrier family 4, sodium borate transporter, member 11 1,022 transporter SPATA2L SPATA2L spermatogenesis associated 2-like -1,451 other SPIN1 SPIN1 spindlin 1 -1,055 other transcription STAT2 STAT2 signal transducer and activator of transcription 2, 113kDa -1,091 regulator TMEM102 TMEM102 transmembrane protein 102 -1,029 other transcription TRIM25 TRIM25 tripartite motif-containing 25 -1,137 regulator USP20 USP20 ubiquitin specific peptidase 20 -1,140 peptidase transcription WT1 WT1 Wilms tumor 1 -1,545 regulator LGICZ1 ZACN zinc activated ligand-gated ion channel 1,089 ion channel ZNF790 ZNF790 zinc finger protein 790 -1,173 other p-value <0.001 .
Load more

Recommended publications
  • Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice
    Loyola University Chicago Loyola eCommons Biology: Faculty Publications and Other Works Faculty Publications 2013 Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice Mihaela Palicev Gunter P. Wagner James P. Noonan Benedikt Hallgrimsson James M. Cheverud Loyola University Chicago, [email protected] Follow this and additional works at: https://ecommons.luc.edu/biology_facpubs Part of the Biology Commons Recommended Citation Palicev, M, GP Wagner, JP Noonan, B Hallgrimsson, and JM Cheverud. "Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice." Genome Biology and Evolution 5(10), 2013. This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has been accepted for inclusion in Biology: Faculty Publications and Other Works by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. © Palicev et al., 2013. GBE Genomic Correlates of Relationship QTL Involved in Fore- versus Hind Limb Divergence in Mice Mihaela Pavlicev1,2,*, Gu¨ nter P. Wagner3, James P. Noonan4, Benedikt Hallgrı´msson5,and James M. Cheverud6 1Konrad Lorenz Institute for Evolution and Cognition Research, Altenberg, Austria 2Department of Pediatrics, Cincinnati Children‘s Hospital Medical Center, Cincinnati, Ohio 3Yale Systems Biology Institute and Department of Ecology and Evolutionary Biology, Yale University 4Department of Genetics, Yale University School of Medicine 5Department of Cell Biology and Anatomy, The McCaig Institute for Bone and Joint Health and the Alberta Children’s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada 6Department of Anatomy and Neurobiology, Washington University *Corresponding author: E-mail: [email protected].
    [Show full text]
  • Epigenome-Wide Association of Father's Smoking
    Environmental Epigenetics, 2019, 1–10 doi: 10.1093/eep/dvz023 Research article RESEARCH ARTICLE Epigenome-wide association of father’s smoking with offspring DNA methylation: a hypothesis-generating study G.T. Mørkve Knudsen1,2,*,†, F.I. Rezwan3,†, A. Johannessen2,4, S.M. Skulstad2, R.J. Bertelsen1, F.G. Real1, S. Krauss-Etschmann5,6, V. Patil7, D. Jarvis8, S.H. Arshad9,10, J.W. Holloway3,‡ and C. Svanes2,4,‡ 1Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway; 2Department of Occupational Medicine, Haukeland University Hospital, N-5021 Bergen, Norway; 3Human Genetics and Genomic Medicine, Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; 4Department of Global Public Health and Primary Care, Centre for International Health, University of Bergen, N-5018 Bergen, Norway; 5Division of Experimental Asthma Research, Research Center Borstel, 23845 Borstel, Germany; 6German Center for Lung Research (DZL) and Institute of Experimental Medicine, Christian- Albrechts University of Kiel, 24118 Kiel, Germany; 7David Hide Asthma and Allergy Research Centre, St. Mary’s Hospital, Isle of Wight PO30 5TG, UK; 8Faculty of Medicine, National Heart & Lung Institute, Imperial College, London SW3 6LY, UK; 9Clinical and Experimental Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK; 10NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton SO16 6YD, UK *Correspondence address. Haukanesvegen 260, N-5650 Tysse, Norway; Tel: þ47 977 98 147; E-mail: [email protected] and [email protected] †Equal first authors. ‡Equal last authors. Managing Editor: Moshe Szyf Abstract Epidemiological studies suggest that father’s smoking might influence their future children’s health, but few studies have addressed whether paternal line effects might be related to altered DNA methylation patterns in the offspring.
    [Show full text]
  • In Silico Prediction of High-Resolution Hi-C Interaction Matrices
    ARTICLE https://doi.org/10.1038/s41467-019-13423-8 OPEN In silico prediction of high-resolution Hi-C interaction matrices Shilu Zhang1, Deborah Chasman 1, Sara Knaack1 & Sushmita Roy1,2* The three-dimensional (3D) organization of the genome plays an important role in gene regulation bringing distal sequence elements in 3D proximity to genes hundreds of kilobases away. Hi-C is a powerful genome-wide technique to study 3D genome organization. Owing to 1234567890():,; experimental costs, high resolution Hi-C datasets are limited to a few cell lines. Computa- tional prediction of Hi-C counts can offer a scalable and inexpensive approach to examine 3D genome organization across multiple cellular contexts. Here we present HiC-Reg, an approach to predict contact counts from one-dimensional regulatory signals. HiC-Reg pre- dictions identify topologically associating domains and significant interactions that are enri- ched for CCCTC-binding factor (CTCF) bidirectional motifs and interactions identified from complementary sources. CTCF and chromatin marks, especially repressive and elongation marks, are most important for HiC-Reg’s predictive performance. Taken together, HiC-Reg provides a powerful framework to generate high-resolution profiles of contact counts that can be used to study individual locus level interactions and higher-order organizational units of the genome. 1 Wisconsin Institute for Discovery, 330 North Orchard Street, Madison, WI 53715, USA. 2 Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53715, USA. *email: [email protected] NATURE COMMUNICATIONS | (2019) 10:5449 | https://doi.org/10.1038/s41467-019-13423-8 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13423-8 he three-dimensional (3D) organization of the genome has Results Temerged as an important component of the gene regulation HiC-Reg for predicting contact count using Random Forests.
    [Show full text]
  • Biomarker Discovery for Chronic Liver Diseases by Multi-Omics
    www.nature.com/scientificreports OPEN Biomarker discovery for chronic liver diseases by multi-omics – a preclinical case study Daniel Veyel1, Kathrin Wenger1, Andre Broermann2, Tom Bretschneider1, Andreas H. Luippold1, Bartlomiej Krawczyk1, Wolfgang Rist 1* & Eric Simon3* Nonalcoholic steatohepatitis (NASH) is a major cause of liver fbrosis with increasing prevalence worldwide. Currently there are no approved drugs available. The development of new therapies is difcult as diagnosis and staging requires biopsies. Consequently, predictive plasma biomarkers would be useful for drug development. Here we present a multi-omics approach to characterize the molecular pathophysiology and to identify new plasma biomarkers in a choline-defcient L-amino acid-defned diet rat NASH model. We analyzed liver samples by RNA-Seq and proteomics, revealing disease relevant signatures and a high correlation between mRNA and protein changes. Comparison to human data showed an overlap of infammatory, metabolic, and developmental pathways. Using proteomics analysis of plasma we identifed mainly secreted proteins that correlate with liver RNA and protein levels. We developed a multi-dimensional attribute ranking approach integrating multi-omics data with liver histology and prior knowledge uncovering known human markers, but also novel candidates. Using regression analysis, we show that the top-ranked markers were highly predictive for fbrosis in our model and hence can serve as preclinical plasma biomarkers. Our approach presented here illustrates the power of multi-omics analyses combined with plasma proteomics and is readily applicable to human biomarker discovery. Nonalcoholic fatty liver disease (NAFLD) is the major liver disease in western countries and is ofen associated with obesity, metabolic syndrome, or type 2 diabetes.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • ACSL6 (C) Antibody, Rabbit Polyclonal
    Order: (888)-282-5810 (Phone) (818)-707-0392 (Fax) [email protected] Web: www.Abiocode.com ACSL6 (C) Antibody, Rabbit Polyclonal Cat#: R2712-2 Lot#: Refer to vial Quantity: 100 ul Application: WB Predicted I Observed M.W.: 78 kDa Uniprot ID: Q9UKU0 Background: Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta- oxidation. ACSL6 plays an important role in fatty acid metabolism in brain and the acyl-CoAs produced may be utilized exclusively for the synthesis of the brain lipid. Translocations with the ETV6 gene are causes of myelodysplastic syndrome with basophilia, acute myelogenous leukemia with eosinophilia, and acute eosinophilic leukemia. Other Names: Long-chain-fatty-acid--CoA ligase 6, Long-chain acyl-CoA synthetase 6, LACS 6, ACS2, FACL6, KIAA0837, LACS5 Source and Purity: Rabbit polyclonal antibodies were produced by immunizing animals with a GST-fusion protein containing C-terminal region of human ACSL6. Antibodies were purified by affinity purification using immunogen. Storage Buffer and Condition: Supplied in 1 x PBS (pH 7.4), 100 ug/ml BSA, 40% Glycerol, 0.01% NaN3. Store at -20 °C. Stable for 6 months from date of receipt. Species Specificity: Human, Mouse Tested Applications: WB: 1:1,000-1:3,000 (detect endogenous protein*) *: The apparent protein size on WB may be different from the calculated M.W. due to modifications. For research use only. Not for therapeutic or diagnostic purposes. Abiocode, Inc., 29397 Agoura Rd., Ste 106, Agoura Hills, CA 91301 Order: (888)-282-5810 (Phone) (818)-707-0392 (Fax) [email protected] Web: www.Abiocode.com Product Data: kDa A B C 175 80 58 46 Fig 1.
    [Show full text]
  • Bioinformatics Analyses of Genomic Imprinting
    Bioinformatics Analyses of Genomic Imprinting Dissertation zur Erlangung des Grades des Doktors der Naturwissenschaften der Naturwissenschaftlich-Technischen Fakultät III Chemie, Pharmazie, Bio- und Werkstoffwissenschaften der Universität des Saarlandes von Barbara Hutter Saarbrücken 2009 Tag des Kolloquiums: 08.12.2009 Dekan: Prof. Dr.-Ing. Stefan Diebels Berichterstatter: Prof. Dr. Volkhard Helms Priv.-Doz. Dr. Martina Paulsen Vorsitz: Prof. Dr. Jörn Walter Akad. Mitarbeiter: Dr. Tihamér Geyer Table of contents Summary________________________________________________________________ I Zusammenfassung ________________________________________________________ I Acknowledgements _______________________________________________________II Abbreviations ___________________________________________________________ III Chapter 1 – Introduction __________________________________________________ 1 1.1 Important terms and concepts related to genomic imprinting __________________________ 2 1.2 CpG islands as regulatory elements ______________________________________________ 3 1.3 Differentially methylated regions and imprinting clusters_____________________________ 6 1.4 Reading the imprint __________________________________________________________ 8 1.5 Chromatin marks at imprinted regions___________________________________________ 10 1.6 Roles of repetitive elements ___________________________________________________ 12 1.7 Functional implications of imprinted genes _______________________________________ 14 1.8 Evolution and parental conflict ________________________________________________
    [Show full text]
  • Congenital Disorders of Glycosylation from a Neurological Perspective
    brain sciences Review Congenital Disorders of Glycosylation from a Neurological Perspective Justyna Paprocka 1,* , Aleksandra Jezela-Stanek 2 , Anna Tylki-Szyma´nska 3 and Stephanie Grunewald 4 1 Department of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, Poland 2 Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland; [email protected] 3 Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, W 04-730 Warsaw, Poland; [email protected] 4 NIHR Biomedical Research Center (BRC), Metabolic Unit, Great Ormond Street Hospital and Institute of Child Health, University College London, London SE1 9RT, UK; [email protected] * Correspondence: [email protected]; Tel.: +48-606-415-888 Abstract: Most plasma proteins, cell membrane proteins and other proteins are glycoproteins with sugar chains attached to the polypeptide-glycans. Glycosylation is the main element of the post- translational transformation of most human proteins. Since glycosylation processes are necessary for many different biological processes, patients present a diverse spectrum of phenotypes and severity of symptoms. The most frequently observed neurological symptoms in congenital disorders of glycosylation (CDG) are: epilepsy, intellectual disability, myopathies, neuropathies and stroke-like episodes. Epilepsy is seen in many CDG subtypes and particularly present in the case of mutations
    [Show full text]
  • Nutrient Health and EROEN Compounds Resegsterixsteextics: Production * Gets Cartrai, Agairaxxxix
    US 2011 O153221A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0153221 A1 Stefanon et al. (43) Pub. Date: Jun. 23, 2011 (54) DIAGNOSTIC SYSTEM FOR SELECTING (52) U.S. Cl. .......................................................... 702/19 NUTRITION AND PHARMACOLOGICAL PRODUCTS FOR ANIMALS (57) ABSTRACT (76) Inventors: Bruno Stefanon, Martignacco (IT): W.Year Jean Dodds.Odds, Santa Monica,IVIon1ca, CA An analysis of the profile of a non-human animal comprises: a) providing a genotypic database to the species of the non (21) Appl. No.: 12/927,769 human animal Subject or a selected group of the species; b obtaining animal data; c) correlating the database of a) with (22) Filed:1-1. Nov. 19, 2010 the data ofb) to determinea relationshipp between the database of a) and the data of b); c) determining the profile of the Related U.S. Application Data animal based on the correlating step; and d) determining a (63)63) ContinuationConti offaroplication application No. 12/316.824,:4'. filed'O geneticmolecular profile dietary based signature on the being molecular a variation dietary of signature, expression the of Dec. 16, 2008, now Pat. No. 7,873,482. a set of genes which may differ for the genotype of each O O animal or a group of animals Nutrition and pharmalogical Publication Classification assessments are made. Reporting the determination is by the (51) Int. Cl. Internet, and payment for the report is obtained through the G06F 9/00 (2011.01) Internet. 38s. 4 gas registics, $88's *.icisixxxiiserscies: 8 texrigixi exsix * processire statisy • Essex: 88& goEffect onXXXXWWYYX Nutrient health and EROEN Compounds resegsterixsteextics: production * gets cartrai, agairaxxxix.
    [Show full text]
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
    [Show full text]
  • Molecular Basis for SPIN·DOC-Spindlin1 Engagement and Its Role in Transcriptional Inhibition
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.07.432812; this version posted March 7, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Molecular basis for SPIN·DOC-Spindlin1 engagement and its role in transcriptional inhibition Fan Zhao1†, Fen Yang2,3†, Fan Feng1, Bo Peng1, Mark T. Bedford2*, and Haitao Li1,4* 1 MOE Key Laboratory of Protein Sciences, Beijing Frontier Research Center for Biological Structure, Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China, 2 Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Smithville, Texas 78957, USA, 3Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, China, 4 Tsinghua-Peking Center for Life Sciences, Beijing 100084, China *To whom correspondence should be addressed. Tel: 86-10-62771392; Email: [email protected]; Correspondence may also be addressed to Mark T. Bedford. Tel: 512-237-9539; Email: [email protected]. ABSTRACT Spindlin1 is a transcriptional coactivator with three Tudor-like domains, of which the first and second Tudors are engaged in histone methylation readout, while the function of the third Tudor is largely unknown. Recent studies revealed that the transcriptional co-activator activity of Spindlin1 could be attenuated by SPIN•DOC. Here we solved the crystal structure of SPIN•DOC-Spindlin1 complex, revealing that a hydrophobic motif, DOCpep3 (256-281), of SPIN•DOC interacts with Tudor 3 of Spindlin1 and completes its β-barrel fold.
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]